China Releases Draft Rules on Data Protection in Pharmaceutical Trials
Chinese authorities have released draft measures to regulate the data protection period of pharmaceutical trials, including those from overseas.
Under the
In the News: Pharma Data Protection Rules; Facial Recognition Restrictions; and UBS Fully Owns Its Chinese Operations
China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate facial recognition technology; and UBS becomes the 5th wholly foreign-owned securities firm in China.
By Brian Chan and Krista Lee